121 employees
Biotheranostics is a commercial-stage molecular diagnostics company that support physicians in the treatment of cancer patients.
2008
$32M
from 3 investors over 3 rounds
bioTheranostics raised $32M on January 21, 2016
Investors: HealthQuest Capital, MVM Partners and Canepa Healthcare, LLC